Recipharm has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.

Located in Israel, Hadasit, a wholly owned subsidiary of Hadassah Medical Organisation (HMO), offers a variety of research, development and consulting services to customers, primarily in the Middle East.

With its unique access to HMO's expert clinicians and researchers, the company provides clinical-oriented R&D services that can assist customers from the point of early preclinical development up to regulatory approval, saving valuable time and money.

Recipharm's facility in Israel has partnered with the firm as part of its growth plans in the market and to enable a more seamless customer experience as pharmaceutical products progress through clinical phases.

Commenting on the partnership, Dr. Sylvia Kachalsky, Site Manager at Recipharm in Israel, said: Developing a drug involves chemical, biological and clinical expertise. Our partnership with Hadasit means we can offer these services more efficiently and manage projects seamlessly from development to clinic.

Recipharm established in Israel in 2015 and since then the business has grown to serve more than 50 customers, primarily in Israel and the USA.

Dr. Kachalsky continued: The partnership will support business growth in Israel, giving Recipharm access to the majority of the clinical trials taking place in the country. While the field of chemistry services is relatively new to this market, the growth potential is substantial, with more than 800 biotech companies in Israel and the number and size of these companies continuing to grow.

By collaborating with one of the most prestigious hospitals in the region and its commercial arm, we believe this will support our goal to become the most trusted CDMO in the region.

Hadasit brings a number of specialist services to the partnership, including in vitro analysis in various models, access to and analysis of human samples, in vivo models for multiple medical conditions, input regarding medical indications and the conducting of clinical trials at all phases.

About Recipharm

Recipharm is a Contract Development and Manufacturing Organization (CDMO)...

To continue reading